Skip to main content
. 2020 Dec 11;55(Suppl 1):22–174. doi: 10.1038/s41409-020-01119-3
Co-morbidity Prevelance of co-morbidity (n) Prevelance of NRM (n) Hazard ratio Weighted score
More than 1 transplant 84 18 1.44 1
Haplo-HSCT, MMFD/MMUD/MMSD, MUD 70, 257, 326 29, 52, 52 4.46, 1.57, 1.12 4, 2, 1
Use of serotherapy, Continuation of prednisolone therapy >0.3 mg/kg beyond D0 620, 70 117, 27 1.96, 1.94 2, 2
Heart valve disease, Any cardiac abnormality 23, 42 6, 11 1.52, 1.08 2, 1
Assisted ventilation at D0, Assisted ventilation at any time point pre-HSCT, Any lung structural abnormality 6, 109, 31 3, 26, 9 5.75, 0.84, 1.94 4, 1, 2
CNS infection, Epilepsy, PRES, CNS structural abnormality 17, 8, 7, 14 8, 3, 4, 6 2.13, 1.03, 3.54, 2.15 2, 1, 4, 2
Chronic diarrhoea, Acute infectious diarrhoea at D0, TPN dependency 67, 13, 72 17, 5, 18 1.14, 2.07, 1.02 1, 2, 1
Presence of respiratory viral infection D-10-D0, Presence of CMV viraemia D-10-D0, Continuation of anti-microbial therapy beyond D0 39, 31, 158 16, 12, 36 3.45, 2.15, 0.98 3, 2, 1
ALT: 52-130 IU/L, ALT more than 130 IU/L, Bilirubin ≥ 33 mmol/L, Creatinine ≥ 1.5 mg/dl 222, 76, 21, 8 48, 20, 10, 3 1.74, 1, 3.82, 2.83 2, 1, 4, 3